Is Thymagen FDA approved?
No. This profile records Thymagen as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE IMMUNE RESTORER
A-3 Peptide; Thymic Bioregulator
Thymagen is a thymus-derived bioregulator peptide that helps restore immune balance. It promotes T-cell differentiation, modulates inflammatory responses, and enhances antioxidant defenses. It's used to restore immune competence after chronic infections, stress, or aging, helping to reverse the immune decline (immunosenescence) that occurs as we get older.
Not FDA approved · research use only
Reviewed by our clinical team
1 research sources
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records Thymagen as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 2 mg subcutaneously daily.
Schedule: daily. Cycle: 4 weeks on, 8 weeks off (2-3 cycles per year). This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 1 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Promotes CD34+ progenitor cell differentiation
Reduces pro-inflammatory while increasing IL-10
Restores thymic epithelial cell markers (FOXN1)
Enhances antioxidant enzymes like SOD2
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.